当前位置:首页 - 行情中心 - 毕得医药(688073) - 财务分析

毕得医药

(688073)

  

流通市值:33.44亿  总市值:70.30亿
流通股本:4323.42万   总股本:9088.29万

毕得医药(688073)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.20亿元,每股收益1.37元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益200246.24万元,未分配利润30179.12万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产256296.17万元,负债56049.93万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入979,111,093.03627,526,589.12296,374,647.621,102,010,333.61
营业总成本809,767,058.8522,427,598.32245,523,164.31931,884,986.72
其他经营收益
营业利润159,784,517.84100,639,047.5643,139,300.44148,334,349.56
利润总额159,566,465.22100,843,826.9143,349,042.99148,018,153.98
净利润119,734,016.4173,406,059.5430,693,093.12117,426,163.51
每股收益
其他综合收益1,945,985.632,453,798.93724,099.55-1,641,272.74
综合收益总额121,680,002.0475,859,858.4731,417,192.67115,784,890.77
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,369,501,774.042,335,754,043.11,707,237,377.892,208,723,169.25
非流动资产:
非流动资产合计193,459,925.96194,435,725962,034,554.98209,311,949.15
资产总计2,562,961,7002,530,189,768.12,669,271,932.872,418,035,118.4
流动负债:
流动负债合计520,035,221.03542,520,437.38593,692,231.04345,761,323.6
非流动负债:
非流动负债合计40,464,112.5438,943,676.5342,208,825.2345,151,331.16
负债合计560,499,333.57581,464,113.91635,901,056.27390,912,654.76
所有者权益(或股东权益):
归属于母公司股东权益合计2,002,462,366.431,948,725,654.192,033,370,876.62,027,122,463.64
股东权益合计2,002,462,366.431,948,725,654.192,033,370,876.62,027,122,463.64
负债和股东权益合计2,562,961,7002,530,189,768.12,669,271,932.872,418,035,118.4
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计997,205,055.86631,163,417.65286,980,156.391,293,712,783.17
经营活动现金流出小计988,472,351.48615,051,229.06279,883,597.41,135,400,077.66
经营活动产生的现金流量净额8,732,704.3816,112,188.597,096,558.99158,312,705.51
投资活动产生的现金流量:
投资活动现金流入小计3,368,193,225.842,001,219,043.6796,578,027.77694,277,207.16
投资活动现金流出小计3,486,621,789.062,399,795,383.16838,293,599.56852,754,867.09
投资活动产生的现金流量净额-118,428,563.22-398,576,339.49-741,715,571.79-158,477,659.93
筹资活动产生的现金流量:
筹资活动现金流入小计279,935,276.04271,010,787.63231,501,858.62104,944,888.52
筹资活动现金流出小计309,855,510.11278,428,623.1546,780,197.83271,787,057.28
筹资活动产生的现金流量净额-29,920,234.07-7,417,835.52184,721,660.79-166,842,168.76
汇率变动对现金及现金等价物的影响-3,268,217.273,350,488.572,458,750.34-1,442,233.01
现金及现金等价物净增加额-142,884,310.18-386,531,497.85-547,438,601.67-168,449,356.19
期末现金及现金等价物余额953,736,388.07710,089,200.4549,182,096.581,096,620,698.25
补充资料:
现金及现金等价物的净增加额--386,531,497.85--168,449,356.19
最新报告期:2025-10-09
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹,王凯旋,韩世通1.652.082.572025-10-09
华创证券郑辰1.622.273.022025-09-26
中泰证券崔少煜,祝嘉琦1.602.243.162025-09-05
信达证券唐爱金1.642.112.692025-08-24
开源证券余汝意,聂媛媛1.562.222.822025-08-24
TOP↑